OncoSwab

OncoSwab

生物技术研究

Simplifying lung cancer detection.

关于我们

75% of lung cancer cases are detected too late. OncoSwab is changing that. Our mission: make early detection accessible with a non-invasive, easy-to-use test. Founded by visionary scientists and supported by the Health Wildcatters Accelerator, Swiss Government's DayOne Tech, and several pre-seed investors, OncoSwab is currently conducting a proof-of-concept trial with the collaboration of top US and European hospitals and lung cancer experts, aiming to save lives worldwide. OncoSwab has offices in San Francisco, California and Corroux, Switzerland.

网站
oncoswab.com
所属行业
生物技术研究
规模
2-10 人
类型
私人持股
创立
2023

OncoSwab员工

动态

相似主页